EP Patent

EP2886544A1 — Process for the preparation of crystalline sitagliptin fumarate

Assigned to Sun Pharmaceutical Industries Ltd · Expires 2015-06-24 · 11y expired

What this patent protects

The present invention provides a process for the preparation of crystalline sitagliptin fumarate.

USPTO Abstract

The present invention provides a process for the preparation of crystalline sitagliptin fumarate.

Drugs covered by this patent

Steglatro (ERTUGLIFLOZIN) · Merck & Co.

Patent Metadata

Patent number: EP2886544A1
Jurisdiction: EP
Classification: —
Expires: 2015-06-24
Drug substance claim: No
Drug product claim: No
Assignee: Sun Pharmaceutical Industries Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.